Clinical Data Cuts FY2010 Loss as Revenues Rise 26 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Following on last week's announcement of preliminary financial results, Clinical Data today reported flat fourth-quarter revenue growth and an increased net loss on higher R&D spending.

The Newton, Mass.-based firm reported a 26 percent increase in its full-year revenues compared to fiscal-year 2009 and sharp decrease in its net loss year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.